XM does not provide services to residents of the United States of America.

Rentokil shares jump as group moves to fix North America business



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Rentokil shares jump as group moves to fix North America business</title></head><body>

Sees 2025 profit and margins hurt by delay in realising Terminix acquisition benefits

N. America Q3 organic revenue growth ahead of H2 guidance range

Results suggest some early traction on growth plan - Jefferies

Adds CEO comment, analysts comment, shares and details

By Shanima A

Oct 17 (Reuters) -British pest control company Rentokil RTO.L reported a 2.6% rise in third-quarter revenue and announced a management overhaul at its struggling North American business on Thursday, sending its shares 8% up.

It said in a statement its North America finance chief has left the business and the group has appointed a new chief marketing officer and chief operating officer in the region. It has yet to appoint a new CFO.

News of the changes helped offset investor disappointment after Rentokil said its profit and margins in 2025 will be hit by a two- to three-month delay in realising the benefits of its acquisition of U.S. rival Terminix.

The company also said organic revenue growth in North America, its biggest market, was 1.4% in the third quarter, indicating that it was tracking ahead of the 1% rise it guided last month for the region in the second half.

Rentokil had last month flagged weaker-than-expected sales in North America - the third warning in the past year. At the time, CEO Andy Ransom had also expressed disappointment on the execution of the group's strategy.

"Results suggest some early traction on growth plan," brokerage Jefferies said in a note.

Rentokil said its North America business has "underperformed" and has been hurt by higher-than-expected material and consumable costs, partly due to inflation. It has also cut about 250 jobs in the region.

Rentokil and rival Rollins ROL.N account for roughly half of the U.S. pest control market, with Rentokil the larger player following its $6.7 billion acquisition of Terminix in 2021.

It said synergies from its integration with Terminix would be delayed by two- to three-months as it pilots new pay plans and new satellite branches in the fourth quarter and plans to review the programs early in the new year.




Reporting by Yamini Kalia and Shanima A in Bengaluru; Editing by Subhranshu Sahu, Savio D'Souza and Emelia Sithole-Matarise

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.